Applying a hypoxia-incorporating TCP model to experimental data on rat sarcoma

Area of Science:

• Radiation oncology
• Mathematical modeling
• Cancer research

Background:

• Hypoxia, or low oxygen levels, significantly impacts radiation therapy outcomes.
• Tumor control probability (TCP) models are crucial for predicting treatment efficacy.
• Understanding tumor reoxygenation is key to optimizing radiotherapy fractionation.

Purpose of the Study:

• To validate a novel tumor control probability (TCP) model incorporating acute and chronic hypoxia.
• To assess the model's ability to describe animal in vivo dose-response data, including tumor reoxygenation.
• To evaluate the model's predictive power for clinical scenarios in non-small cell lung cancer.

Main Methods:

• A mechanistic tumor control probability (TCP) model accounting for tumor repopulation and fluctuating hypoxia was developed.
• The model was fitted to existing animal in vivo dose-response data (Fischer-Moulder) and cell survival data (Reinhold) using maximum likelihood estimation.
• Hypoxia-related parameters were optimized to accurately represent tumor radiobiology.

Main Results:

• The model demonstrated a statistically acceptable fit to the combined animal data.
• Best-fit parameters were consistent with published values, and cell survival curves matched experimental observations.
• The model successfully described inverse dose behavior in response curves, attributed to tumor reoxygenation.

Conclusions:

• The validated TCP model accurately describes animal in vivo data exhibiting tumor reoxygenation.
• The model predicts a significant decrease in tumor control probability with fewer than 10 fractions.
• Findings caution against the use of severely hypofractionated radiotherapy schedules in clinical practice.